New Insights into the Use of Liraglutide-Impact on Cardiovascular Risk and Microvascular Outcomes.

Wronka, Magdalena; Krzeminska, Julia; Mlynarska, Ewelina; Rysz, Jacek; Franczyk, Beata

Wronka, Magdalena; Krzeminska, Julia; Mlynarska, Ewelina; Rysz, Jacek; Franczyk, Beata.

Afiliação

Wronka M; Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland.
Krzeminska J; Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland.
Mlynarska E; Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland.
Rysz J; Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland.
Franczyk B; Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland.

Biomedicines ; 11(4)2023 Apr 12.

Article em En | MEDLINE | ID: mdl-37189777

Palavras-chave

cardiovascular risk; glucagon-like peptides-1; liraglutide; microvascular; type 2 diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google